Zydus Cadila Healthcare Limited - Product Pipeline Review - 2012 - This pharmaceuticals report, "Zydus Cadila Healthcare Limited - Product Pipeline Review - 2012" provides data on the Zydus Cadila Healthcare Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from our proprietary databases, Zydus Cadila Healthcare Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Zydus Cadila Healthcare Limited and industry-specific third party sources, put together by This team.
Scope
- Zydus Cadila Healthcare Limited - Brief Zydus Cadila Healthcare Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Zydus Cadila Healthcare Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Zydus Cadila Healthcare Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Zydus Cadila Healthcare Limited's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Zydus Cadila Healthcare Limited's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Zydus Cadila Healthcare Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Zydus Cadila Healthcare Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Zydus Cadila Healthcare Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Zydus Cadila Healthcare Limited and identify potential opportunities in those areas.
Keywords
Current R&D Portfolio of Zydus Cadila Healthcare Limited; Zydus Cadila Healthcare Limited - Key Therapeutics; Zydus Cadila Healthcare Limited - Pipeline Overview and Promising Molecules; Zydus Cadila Healthcare Limited - News; Zydus Cadila Healthcare Limited - Latest Updates; Zydus Cadila Healthcare Limited - Pipeline; Zydus Cadila Healthcare Limited - Discontinued/Dormant Projects
Table of Contents
Table of Contents
List of Tables
List of Figures
Zydus Cadila Healthcare Limited Snapshot
Zydus Cadila Healthcare Limited Overview
Key Information
Key Facts
Zydus Cadila Healthcare Limited - Research and Development Overview
Key Therapeutic Areas
Zydus Cadila Healthcare Limited - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Zydus Cadila Healthcare Limited - Pipeline Products Glance
Zydus Cadila Healthcare Limited - Late Stage Pipeline
Registration Filed Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Zydus Cadila Healthcare Limited Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Zydus Cadila Healthcare Limited - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Zydus Cadila Healthcare Limited - Drug Profiles
Blonanserin
Product Description
Mechanism of Action
R&D Progress
Drug For Atherosclerotic Plaque
Product Description
Mechanism of Action
R&D Progress
IFN-Beta-1b
Product Description
Mechanism of Action
R&D Progress
MAb 1
Product Description
Mechanism of Action
R&D Progress
MAb 3
Product Description
Mechanism of Action
R&D Progress
MAb 4
Product Description
Mechanism of Action
R&D Progress
PEG-EPO
Product Description
Mechanism of Action
R&D Progress
Prod 1
Product Description
Mechanism of Action
R&D Progress
Prod 2
Product Description
Mechanism of Action
R&D Progress
Prod 3
Product Description
Mechanism of Action
R&D Progress
Prod 4
Product Description
Mechanism of Action
R&D Progress
Prod 5
Product Description
Mechanism of Action
R&D Progress
Prod 7
Product Description
Mechanism of Action
R&D Progress
Prod-6
Product Description
Mechanism of Action
R&D Progress
Teriparatide
Product Description
Mechanism of Action
R&D Progress
ZYD1
Product Description
Mechanism of Action
R&D Progress
ZYG19
Product Description
Mechanism of Action
R&D Progress
ZYGK1
Product Description
Mechanism of Action
R&D Progress
ZYGL241
Product Description
Mechanism of Action
R&D Progress
ZYH1
Product Description
Mechanism of Action
R&D Progress
ZYH7
Product Description
Mechanism of Action
R&D Progress
ZYOG1
Product Description
Mechanism of Action
R&D Progress
ZYPH0907
Product Description
Mechanism of Action
R&D Progress
ZYT1
Product Description
Mechanism of Action
R&D Progress
Zydus Cadila Healthcare Limited - Pipeline Analysis
Zydus Cadila Healthcare Limited - Pipeline Products by Therapeutic Class
Zydus Cadila Healthcare Limited - Pipeline Products by Route of Administration
Zydus Cadila Healthcare Limited - Pipeline Products By Mechanism of Action
Zydus Cadila Healthcare Limited - Recent Pipeline Updates
Zydus Cadila Healthcare Limited - Dormant Projects
Zydus Cadila Healthcare Limited - Company Statement
Zydus Cadila Healthcare Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Zydus Cadila Healthcare Limited, Recent Developments
Zydus Cadila Healthcare Limited- Press Release
Jun 04, 2009: Zydus Files IND Application With The DCGI For 'ZYD1' - A Novel Candidate To Treat Diabetes And Obesity
May 05, 2009: Zydus Receives FDA Approval For Mycophenolate Mofetil Tablets And Capsules
Apr 02, 2009: Zydus Files IND Application With The USFDA For ZYT1, A Novel Candidate To Treat Dyslipidemia
Mar 31, 2009: Zydus Receives FDA Approval For Topiramate Tablets
Financial Deals Landscape
Zydus Cadila Healthcare Limited, Deals Summary
Zydus Cadila Healthcare Limited, Pharmaceuticals & Healthcare, Deal Details
Partnerships
Microbix Biosystems Announces Co-Marketing Agreement With Zydus Cadila For Urokinase
Karo Bio Extends Research Agreement With Zydus Cadila
Bayer HealthCare Enters Into Joint Venture Agreement With Zydus Cadila Healthcare
Zydus Cadila Signs An Agreement With Eli Lilly
Nycomed Signs An Agreement With Zydus Cadila
Karo Bio Enters Into An Agreement With Zydus Cadila
Zydus Cadila Enters Into Co-Development With Prolong Pharma
Zydus Cadila Enters Into Joint Venture With TGL Enterprises
Hospira Enters Into Joint Venture Agreement With Cadila Healthcare
Licensing Agreements
Abbott Enters Into Licensing Agreement With Zydus Cadila
Debt Offering
Cadila Healthcare Announces Public Offering Of Bonds For $33.5 Million
Acquisition
Zydus Cadila Acquires Biochem Pharma
Cadila Healthcare Acquires Remaining 30% Stake In Simayla Pharma
Cadila Healthcare Acquires 30% Stake In Zydus Pharma USA
Zydus Cadila Acquires Etna Biotech From Crucell
Cadila Healthcare Acquires 70% Stake In Simayla Pharma
Cadila Healthcare Acquires Laboratorios Combix
Zydus Healthcare Brasil Acquires Quimica e Farmaceutica Nikkho do Brasil
Cadila Healthcare Acquires Nippon Universal Pharma
Zydus Cadila Healthcare Acquires Liva Healthcare
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Zydus Cadila Healthcare Limited, Key Information
Zydus Cadila Healthcare Limited, Key Facts
Zydus Cadila Healthcare Limited - Pipeline by Indication, 2012
Zydus Cadila Healthcare Limited - Pipeline by Stage of Development, 2012
Zydus Cadila Healthcare Limited - Monotherapy Products in Pipeline, 2012
Zydus Cadila Healthcare Limited - Filed, 2012
Zydus Cadila Healthcare Limited - Phase III, 2012
Zydus Cadila Healthcare Limited - Phase II, 2012
Zydus Cadila Healthcare Limited - Phase I, 2012
Zydus Cadila Healthcare Limited - Pre-Clinical, 2012
Zydus Cadila Healthcare Limited - Discovery, 2012
Zydus Cadila Healthcare Limited - Pipeline By Therapeutic Class, 2012
Zydus Cadila Healthcare Limited - Pipeline By Route of Administration, 2012
Zydus Cadila Healthcare Limited - Pipeline Products By Mechanism of Action, 2012
Zydus Cadila Healthcare Limited - Recent Pipeline Updates, 2012
Zydus Cadila Healthcare Limited - Dormant Developmental Projects,2012
Zydus Cadila Healthcare Limited, Subsidiaries
Zydus Cadila Healthcare Limited, Deals Summary
Microbix Biosystems Announces Co-Marketing Agreement With Zydus Cadila For Urokinase
Karo Bio Extends Research Agreement With Zydus Cadila
Bayer HealthCare Enters Into Joint Venture Agreement With Zydus Cadila Healthcare
Zydus Cadila Signs An Agreement With Eli Lilly
Nycomed Signs An Agreement With Zydus Cadila
Karo Bio Enters Into An Agreement With Zydus Cadila
Zydus Cadila Enters Into Co-Development With Prolong Pharma
Zydus Cadila Enters Into Joint Venture With TGL Enterprises
Hospira Enters Into Joint Venture Agreement With Cadila Healthcare
Abbott Enters Into Licensing Agreement With Zydus Cadila
Cadila Healthcare Announces Public Offering Of Bonds For $33.5 Million
Zydus Cadila Acquires Biochem Pharma
Cadila Healthcare Acquires Remaining 30% Stake In Simayla Pharma
Cadila Healthcare Acquires 30% Stake In Zydus Pharma USA
Zydus Cadila Acquires Etna Biotech From Crucell
Cadila Healthcare Acquires 70% Stake In Simayla Pharma
Cadila Healthcare Acquires Laboratorios Combix
Zydus Healthcare Brasil Acquires Quimica e Farmaceutica Nikkho do Brasil
Cadila Healthcare Acquires Nippon Universal Pharma
Zydus Cadila Healthcare Acquires Liva Healthcare
List of Figures
Zydus Cadila Healthcare Limited - Pipeline by Indication, 2012
Zydus Cadila Healthcare Limited - Pipeline by Stage of Development, 2012
Zydus Cadila Healthcare Limited - Monotherapy Products in Pipeline, 2012
Zydus Cadila Healthcare Limited - Pipeline By Route of Administration, 2012
Zydus Cadila Healthcare Limited - Pipeline Products By Mechanism of Action, 2012 46